ホーム › クローン病 › ミズーリ州 › St. Louis
St. Louis、MOにおけるクローン病の臨床試験
St. Louisとその周辺地域（約30マイル以内）の拠点で、クローン病に関する19件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
被験者募集中第2相
- Specialists In Gastroenterology /ID# 283939, St Louis
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
被験者募集中第1相
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- 他1件
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
被験者募集中第3相
- Washington University School of Medicine ( Site 5058), St Louis
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
被験者募集中第4相
- SSM Health Medical Group, Bridgeton · 15マイル先
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
被験者募集中第2相
- Washington University /ID# 266938, St Louis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
被験者募集中第3相
- Washington University School of Medicine, St Louis
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Washington University School of Medicine-Site Number: 8400075, St Louis
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
被験者募集中第3相
- Gateway Gastroenterology-Site Number: 8400097, St Louis
A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
被験者募集中第3相
- Washington University School of Medicine, St Louis
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
被験者募集中第2相
- KAD Clinical Research, St Louis
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
被験者募集中第2相
- SSM Health DePaul Hospital- St. Louis, Bridgeton · 15マイル先
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
被験者募集中第2相
- KAD Clinical Research, St Louis
A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease
被験者募集中第4相
- Washington University School of Medicine, St Louis
DB-3Q for the Treatment of Medically Refractory Crohn's Disease
被験者募集中第2相
- Washington University, St. Louis, St Louis
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
被験者募集中第2相
- Washington University School of Medicine, St Louis
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
被験者募集中第2相
- Investigational Site Number: 8400013, St Louis
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
被験者募集中第2相
- Mirador Therapeutics Selected Site, Bridgeton · 15マイル先
Treatment of Moderate to Severe Refractory Crohn's Disease
被験者募集中第1/2相
- Washington University in St. Louis, St Louis
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy
被験者募集中観察研究
- Washington University in St Louis School of Medicine, St Louis
他の都市におけるクローン病の試験
- New York City, NY35件の研究
- Boston, MA19件の研究
- Miami, FL19件の研究
- Cleveland, OH19件の研究
- Tyler, TX17件の研究
- Houston, TX17件の研究
- Orlando, FL17件の研究
- Atlanta, GA17件の研究
- San Antonio, TX15件の研究
- San Diego, CA15件の研究
- Los Angeles, CA15件の研究
- Colorado Springs, CO13件の研究
St. Louisにおける他の研究
- 非小細胞肺癌73件の研究
- 乳がん64件の研究
- 転移性癌54件の研究
- 大腸癌50件の研究
- がん（全種類）46件の研究
- 前立腺がん46件の研究
- 肺がん39件の研究
- 卵巣がん38件の研究
- 膵臓がん33件の研究
- 子宮内膜がん29件の研究
- 頭頸部扁平上皮癌28件の研究
- 心不全26件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。